Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Pentixafor PET/CT for Staging of Hematological Malignancies: Comparison to [18F]FDG PET/CT

NCT06834412 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06834412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Pentixafor PET/CT for Staging of Hematological Malignancies: Comparison to [18F]FDG PET/CT
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 3, 2021
Completion date
December 1, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies